(Q45942355)

18 December 2017

title

Implementing anticoagulation management by pharmacists in the inpatient setting. (English)

1 reference

18 December 2017

1 reference

William E Dager

1

1 reference

18 December 2017

Michael P Gulseth

series ordinal

2

1 reference

18 December 2017

language of work or name

1 reference

1 May 2007

1 reference

18 December 2017

American Journal of Health-System Pharmacy

published in

1 reference

18 December 2017

volume

64

1 reference

18 December 2017

issue

10

1 reference

18 December 2017

page(s)

1071-1079

1 reference

18 December 2017

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Clinical and economic effectiveness of an inpatient anticoagulation service

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Pharmacist involvement with warfarin dosing for inpatients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Pharmacy-managed protocol for warfarin use in orthopedic surgery patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: the LEAP Program

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

A disease management protocol for outpatient perioperative bridge therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Pharmacy-managed anticoagulation: assessment of in-hospital efficacy and evaluation of financial impact and community acceptance

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Pharmacist-provided anticoagulation management in United States hospitals: death rates, length of stay, Medicare charges, bleeding complications, and transfusions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Assessment of an age-adjusted warfarin initiation protocol

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

A randomized trial comparing 5-mg and 10-mg warfarin loading doses.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Initiating warfarin therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Adverse drug events in emergency department patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Incidence and preventability of adverse drug events among older persons in the ambulatory setting

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Ambient air pollution and acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060133

31 March 2020

Identifiers

DOI

10.2146/AJHP060133

1 reference

18 December 2017

1 reference

18 December 2017